Company intelligence / Profile preview

Vivosonic

Ownership: Private
Development stage: Other

Overview

Vivosonic’s Integrity™ V500 System is commercially available and widely used in over 55 countries. It enables reliable auditory diagnostic testing, including ABR and OAE measurements, even in awake infants or electrically noisy environments such as NICU or operating rooms. The system reduces the need for sedation, improves patient comfort, decreases wait times for assessments, and supports teleaudiology applications[1][2][3].

Therapeutic areas: NeurologyOther
Modalities: DeviceDiagnostic equipment (specifically for auditory evoked potentials and otoacoustic emissions)
Industry: Physiological Monitoring

Partnerships

Distributed through a global distributor network in over 55 countries[1][4]. No specific major pharma/biotech partnerships identified.

Beyond the preview

Go deeper on Vivosonic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vivosonic.

Explore the full profile